The role of the CPNKEKEC sequence in the β2 subunit I domain in regulation of integrin αLβ2 (LFA-1)

被引:49
作者
Kamata, T
Tieu, KK
Tarui, T
Puzon-McLaughlin, W
Hogg, N
Takada, Y
机构
[1] Scripps Res Inst, Dept Cell Biol, La Jolla, CA 92037 USA
[2] Imperial Canc Res Fund, Leukocyte Adhes Lab, London WC2A 3PX, England
关键词
D O I
10.4049/jimmunol.168.5.2296
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The alpha(L) I (inserted or interactive) domain of integrin alpha(L)beta(2) undergoes conformational changes upon activation. Recent studies show that the isolated, activated aL I domain is sufficient for strong ligand binding, suggesting the (32 subunit to be only indirectly involved. It has been unclear whether the activity, of the a, I domain is regulated by the (32 subunit. In this study, we demonstrate that swapping the disulfide-Linked CPNKEKEC sequence (residues 169-176) in the alpha(L) I domain with a corresponding beta(3) sequence, or mutating Lys(174) to Thr, constitutively activates alpha(L)beta(2) binding to ICAM-1. These mutants do not require Mn2+ for ICAM-1 binding and are insensitive to the inhibitory effect of Ca2+. We have also localized a component of the mAb 24 epitope (a reporter of beta(2) integrin activation) in the CPNKEKEC sequence. Glu(173) and Glu(175) of the beta(2) I domain are identified as critical for mAb 24 binding. Because the epitope is highly expressed upon beta(2) integrin activation, it is likely that the CPNKEKEC sequence is exposed or undergoes conformational changes upon activation. Deletion of the alpha(L) I domain did not eliminate the crab 24 epitope. This confirms that the alpha(L) I domain is not critical for mAb 24 binding, and indicates that mAb 24 detects a change expressed in part in the beta(2) subunit I domain. These results suggest that the CPNKEKEC sequence of the beta(2) I domain is involved in regulating the alpha(L) I domain.
引用
收藏
页码:2296 / 2301
页数:6
相关论文
共 44 条
  • [1] POINT MUTATIONS IMPAIRING CELL-SURFACE EXPRESSION OF THE COMMON BETA-SUBUNIT (CD-18) IN A PATIENT WITH LEUKOCYTE ADHESION MOLECULE (LEU-CAM) DEFICIENCY
    ARNAOUT, MA
    DANA, N
    GUPTA, SK
    TENEN, DG
    FATHALLAH, DM
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1990, 85 (03) : 977 - 981
  • [2] BETA(2) (CD18) MUTATIONS ABOLISH LIGAND RECOGNITION BY I-DOMAIN INTEGRINS LFA-1 (ALPHA(L)BETA(2), CD11A/CD18) AND MAC-1 (ALPHA(M)BETA(2), CD11B/CD18)
    BAJT, ML
    GOODMAN, T
    MCGUIRE, SL
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (01) : 94 - 98
  • [3] BAZIL V, 1990, FOLIA BIOL-PRAGUE, V36, P41
  • [4] Peptide ligands can bind to distinct sites in integrin αIIbβ3 and elicit different functional responses
    Cierniewski, CS
    Byzova, T
    Papierak, M
    Haas, TA
    Niewiarowska, J
    Zhang, L
    Cieslak, M
    Plow, EF
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (24) : 16923 - 16932
  • [5] SITE-DIRECTED MUTAGENESIS OF VIRTUALLY ANY PLASMID BY ELIMINATING A UNIQUE SITE
    DENG, WP
    NICKOLOFF, JA
    [J]. ANALYTICAL BIOCHEMISTRY, 1992, 200 (01) : 81 - 88
  • [6] THE DYNAMIC REGULATION OF INTEGRIN ADHESIVENESS
    DIAMOND, MS
    SPRINGER, TA
    [J]. CURRENT BIOLOGY, 1994, 4 (06) : 506 - 517
  • [7] INTERACTION OF LEUKOCYTE INTEGRINS WITH LIGAND IS NECESSARY BUT NOT SUFFICIENT FOR FUNCTION
    DRANSFIELD, I
    CABANAS, C
    BARRETT, J
    HOGG, N
    [J]. JOURNAL OF CELL BIOLOGY, 1992, 116 (06) : 1527 - 1535
  • [8] EARLY EVENTS OF THE IMMUNE-RESPONSE MEDIATED BY LEUKOCYTE INTEGRINS
    DRANSFIELD, I
    BUCKLE, AM
    HOGG, N
    [J]. IMMUNOLOGICAL REVIEWS, 1990, 114 : 29 - 44
  • [9] DIVALENT-CATION REGULATION OF THE FUNCTION OF THE LEUKOCYTE INTEGRIN LFA-1
    DRANSFIELD, I
    CABANAS, C
    CRAIG, A
    HOGG, N
    [J]. JOURNAL OF CELL BIOLOGY, 1992, 116 (01) : 219 - 226
  • [10] REGULATED EXPRESSION OF MG-2+ BINDING EPITOPE ON LEUKOCYTE INTEGRIN ALPHA-SUBUNITS
    DRANSFIELD, I
    HOGG, N
    [J]. EMBO JOURNAL, 1989, 8 (12) : 3759 - 3765